Dr. Applewhite is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
See Dr. Applewhite's full profile
Office1129 Macklind Ave
Saint Louis, MO 63110Phone+1 314-534-0200Fax+1 314-534-7996
- Is this information wrong?
- I am a board-certified psychiatrist who treats patients over 18 years in an outpatient setting. I completed my B.A. At Washington University in St. Louis in 2005 with concentrations in Spanish and International Studies. I speak both Spanish and Portuguese fluently. I achieved my M.D. from St. Louis University School of Medicine in 2009. I was granted achievement awards in both Psychiatry and Infectious Disease at graduation. I completed my Psychiatry residency at Washington University School of Medicine in 2013. I have conducted research in vaccine development (T. cruzi), collaborative care in Mental Health, medication trials among patients with Parkinson's Disease (Pimavanserin), and the treatment of psychogenic movement disorders. My practice offers outpatient treatment with medication management and evidence-based psychotherapeutic modalities.
Education & Training
- Washington University/B-JH/SLCH ConsortiumResidency, Psychiatry, 2009 - 2013
- Saint Louis University School of MedicineClass of 2009
- Washington University in St. LouisBA, Spanish and International Studies, 2001 - 2005
Certifications & Licensure
- MO State Medical License 2013 - 2024
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- Morton M. Weber Award for Excellence in Infectious Disease Saint Louis University School of Medicine, 2009
- Samuel W. Fordyce Award for Excellence in Psychiatry 2009
- Phi Beta Kappa Washington University in St. Louis, 2005
- Join now to see all
Publications & Presentations
- Co-Investigator"A Multi-Centered, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of Pimavanserin in the Treatment of Psychosis in Parkinson's Disease."2011 - 2011
- Junior Investigator"Induction of protective mucosal and systemic Trypanosoma cruzi immunity with liposomal Trans-Sialidase recombinant protein and CpG oligodeoxynucleotide administration."2006 - 2006
- Spanish, Portuguese
- Psychology Today Provider Profilehttps://therapists.psychologytoday.com/324449
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: